Fundraising Fox
Glooko
Palo Alto, US · Founded 2010 · Delaware corporation · 236 employees on LinkedIn · 13 known investors
Find your way into Glooko
Sign up to see every warm intro you have to Glooko
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Glooko team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring. It serves healthcare providers and clinics managing people with diabetes, integrating with device makers such as Abbott, Dexcom, Insulet, and Tandem, and with EHR systems including Epic and Oracle Health.
Founders & leadership
CD
Clay DavidsonGeneral CounselClay Davidson is General Counsel at Glooko, a diabetes management platform provider. He joined the company in 2019 as External Legal Consultant and has led the Legal & Privacy team, gaining expertise in healthcare law, data privacy, and regulatory compliance across multiple jurisdictions.
PM
Prakash MenonChief Technology OfficerPrakash Menon holds a B.Tech in Mechanical Engineering and an MBA in Systems & Marketing. He spent nine years at Oracle before joining Glooko, where he led a 100+ person technical organization across five international locations and served as Interim CEO, overseeing platform integrations with 200+ medical devices, cloud infrastructure optimization, regulatory compliance including FDA submissions and HITRUST certification, and technical architecture scaling across 30+ markets.
EM
Ed MarshallExecutive
DP
David PassPresident, Life Sciences2023–2025David Pass is Executive Officer at Glooko, a cloud-connected diabetes management platform integrating device data and clinical workflows for healthcare providers. He previously held leadership roles in pharmaceutical, biotech, and medical device companies, including experience scaling diabetes-focused business units and raising capital for commercial operations.
AH
Adam HameedStrategic growth initiatives and former President, Connected Care2024–2025Adam Hameed brings over three decades of healthcare industry experience, including 25+ years in commercial and growth leadership roles at digital health and technology-enabled companies. He previously held senior leadership positions at Arine, Andros, Cricket Health, PlanSource, Alegeus, Silverlink Communications, and Change Healthcare, and started his healthcare career at Optum; he holds a B.S. in Electrical Engineering and an MBA from the University of Michigan.
MB
Mark BeuclerChief Executive Officer | President | Board MemberMark Beucler brings over 20 years of healthcare leadership experience, most recently as CEO of Qardio, and previously holding senior roles at Medtronic, St. Jude Medical, and Sanofi. He is now Executive Officer at Glooko, which operates a cloud-connected diabetes management platform integrating data from connected devices and insulin pumps into clinical workflows.
RJ
KS
Komathi StemChief Operating Officer2020–2024Komathi Stem has over 30 years of experience in drug development and healthcare IT, having held leadership roles in R&D and commercial functions at major pharmaceutical companies including Eli Lilly, AstraZeneca, and Genentech, and co-founded Science 37 and monARC Bionetworks. She is now Executive Officer at Glooko, which operates a cloud-connected diabetes management platform for healthcare providers.
SL
Steve LienExecutive
SM
Sundeep MadraFounder
Investors · 13
Canaan Partnerslisted by Canaan PartnersStamford · $500K – $20Mvia Wende Hutton · board
How we know: Canaan Partners's portfolio page · a partner's Signal profile · board seat on SEC Form D · funding news · techcrunch.com · open dataset · 5k.vc investor directory · Not right? Tell us
Health Catalyst Capitallisted by Health Catalyst CapitalNew York
How we know: Health Catalyst Capital's portfolio page · funding news · glooko.com · Not right? Tell us
Realization Capital Partnerslisted by Realization Capital PartnersMenlo Park · $1M – $100M
How we know: Realization Capital Partners's portfolio page · Not right? Tell us
Samsung Nextlisted by Samsung NextSan Jose · $100K – $5M
How we know: Samsung Next's portfolio page · techcrunch.com · Not right? Tell us
Social Capital PartnershipreportedPalo Alto
How we know: funding news · Not right? Tell us
Also in the syndicate · 6
Georgian PartnersleadInsuletInsulet CorporationMedtronicNovo NordiskSamsung
Funding
SEC filings, press & company announcements$30M disclosed across 1 of 6 rounds · 2015–2024
- Undisclosed amountSeries CJun 2017
Georgian Partners (lead), Canaan Partners, Insulet Corporation, Mayo Clinic, Medtronic, Samsung Next, Social Capital
Source ↗ - Undisclosed amountSeries BMar 2015
Canaan Partners, Medtronic, Samsung, Social + Capital
Source ↗
▶$124MofferedAug 2024 · Other Health CareRule 506(b)
▶$124MofferedAug 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Clay DavidsonExecutive Officer
- Prakash MenonExecutive Officer
- Wende HuttonDirector
- Ed MarshallExecutive Officer
- David PassExecutive Officer
- Charles BooradyDirector
- Adam HameedExecutive Officer
- Mark BeuclerExecutive Officer
- Simon ChongDirector
- Enrique ConternoDirector
- Russ JohannessonExecutive Officer
- Tracy BahlDirector
- Offering amount
- $124M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$67MofferedAug 2023 · Other Health CareRule 506(b)
▶$67MofferedAug 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Charles BooradyDirector
- Komathi StemExecutive Officer
- Steve LienExecutive Officer
- Ed MarshallExecutive Officer
- Tracy BahlDirector
- Christina DickersonExecutive Officer
- Alfonso ZuluetaDirector
- Clay DavidsonExecutive Officer
- Yogen DalalDirector
- Simon ChongDirector
- Prakash MenonExecutive Officer
- Wende HuttonDirector
- Russ JohannessonExecutive Officer, Director
- Offering amount
- $67M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedMar 2021 · 11 investors · Other Health CareRule 506(b)
▶$30MraisedMar 2021 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Yogen DalalDirector
- Zach HendersonExecutive Officer
- Steve LienExecutive Officer
- Russ JohannessonExecutive Officer, Director
- Clay DavidsonExecutive Officer
- Komathi SternExecutive Officer
- Charles BooradyDirector
- Mike DohertyDirector
- Simon ChongDirector
- Wende HuttonDirector
- Offering amount
- $35M
- Amount sold
- $30M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Glooko went on to found or lead other companies.
Related companies · 3
DiabetesA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.
DexComDexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver. Its products serve people managing diabetes as well as consumers tracking glucose for general health, diet, and exercise.
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Companies working in the same space as Glooko.
In the news
Frequently asked questions
- What does Glooko do?
- Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring. It serves healthcare providers and clinics managing people with diabetes, integrating with device makers such as Abbott, Dexcom, Insulet, and Tandem, and with EHR systems including Epic and Oracle Health.
- Who are Glooko's investors?
- Glooko's investors include Canaan Partners, Health Catalyst Capital, Realization Capital Partners, Samsung Next, Georgian, Mayo Clinic Ventures, Social Capital Partnership.
- How much funding has Glooko raised?
- Glooko has disclosed $30M raised across 1 of its 6 known rounds.
- Where is Glooko headquartered?
- Glooko is headquartered in Palo Alto, US.